新闻 打印 2022Mayo Clinic research shows bebtelovimab to be a reliable option for treating COVID-19 in era of BA.2, other subvariants Aug. 15, 2022, 02:09 p.m. CDT2021Post-COVID symptoms: Women differ distinctly from men Dec. 02, 2021, 05:22 p.m. CDT2020Remote patient monitoring provides patients with comprehensive care at home June 08, 2020, 04:05 p.m. CDT PST-20308858 主页 新闻